全球整容手術市場:市場規模、區域前景、競爭策略以及按性別、手術、年齡層、提供者和最終用戶分類的細分市場預測(截至 2033 年)
市場調查報告書
商品編碼
1421520

全球整容手術市場:市場規模、區域前景、競爭策略以及按性別、手術、年齡層、提供者和最終用戶分類的細分市場預測(截至 2033 年)

Cosmetic Surgery Market Size- By Gender, By Procedure, By Age Group, By Provider, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 255 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計2033年,整容手術市場規模將達到650.8億美元,複合年成長率為4.11%。

本報告調查了全球整容手術市場,並提供了市場概況、市場影響因素和市場機會分析、市場規模趨勢和預測、各個細分市場和地區的詳細分析、競爭形勢、主要企業簡介等。總結。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第4章市場動態

  • 促進因素、限制因素、機會與挑戰分析
  • COVID-19 對市場的影響

第5章 市場變數與展望

  • SWOT分析
  • PESTEL分析
  • 波特五力分析
  • 熱圖分析

第6章 競爭形勢

  • 製造地、銷售區域、產品類型分佈
  • 併購、聯盟、產品發布、合作

第7章全球整容市場:性別

  • 全球市佔率及預測
  • 女士
  • 男性

第8章全球整容手術市場:依程序分類

  • 全球市佔率及預測
  • 非手術治療
  • 手術過程

第9章全球整容手術市場:依年齡層別

  • 全球市佔率及預測
  • 18歲以下
  • 19-34歲
  • 35-50歲
  • 51-64歲
  • 65歲以上

第10章全球整容手術市場:依供應商分類

  • 全球市佔率及預測
  • 醫院/專科診所
  • 水療/美容手術中心

第11章全球整容手術市場預測

  • 市場規模/市場佔有率

第12章全球整容手術市場:性別

  • 市場規模/市場佔有率趨勢/預測

第13章全球整容手術市場:依程序分類

  • 市場規模/市場佔有率趨勢/預測

第14章全球整容手術市場:依年齡層別

  • 市場規模/市場佔有率趨勢/預測

第15章全球整容手術市場:依供應商分類

  • 市場規模/市場佔有率趨勢/預測

第16章全球整容手術市場:按地區

  • 市場規模/市場佔有率趨勢/預測
  • 亞太地區
  • 歐洲
  • 中東/非洲
  • 北美洲
  • 拉丁美洲

第17章 公司簡介

  • AbbVie Inc.
  • Apyx Medical
  • Bausch Health Companies Inc.
  • Cutera
  • Cynosure
  • GALDERMA
  • Johnson & Johnson Services, Inc.
  • Long Island Plastic Surgical Group, PC
  • Merz Pharma
  • Sientra Inc.
  • 其他

第18章簡稱表

第19章 參考鏈接

第20章結論

第21章 研究範圍

簡介目錄
Product Code: FMCG2415

Introduction and Overview

According to SPER market research, 'Cosmetic Surgery Market Size- By Gender, By Procedure, By Age Group, By Provider- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Cosmetic Surgery Market is predicted to reach USD 65.08 billion by 2033 with a CAGR of 4.11%.

The purpose of cosmetic plastic surgery is to alter your appearance. For some, this could entail reshaping the body, removing bald spots, or smoothing out wrinkles. Others might decide for breast augmentation or treatment for varicose veins. The procedure is elective and performed more for aesthetic than for medicinal purposes. Men and women can pick from a variety of cosmetic surgery procedures to create an image that increases their sense of self-assurance and comfort with their looks.

Because of the lockdown and travel restrictions brought on by the COVID-19 pandemic, which hindered hospital and clinic patient chains, the global market for cosmetic surgery was significantly impacted. In order to reduce the possibility of cross-contamination among patients and medical personnel, the health care facilities chose to perform emergency and major*surgeries. Additionally, it restricted people's discretionary cash, which had an immediate effect on the demand for cosmetic surgery.

Scope of the Report

Report Metric Details:

  • Market size available for years: 2019-2033
  • Base year considered: 2022
  • Forecast period: 2023-2033
  • Segments covered: By Gender, By Procedure, By Age Group, By Provider.
  • Regions covered: North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
  • Companies Covered: AbbVie Inc., Apyx Medical, Bausch Health Companies Inc., Cutera, Cynosure, GALDERMA, Johnson & Johnson Services, Inc., Long Island Plastic Surgical Group, PC, Merz Pharma, Sientra, Inc.

Market Segmentation

  • By Gender: Based on the Gender, Global Cosmetic Surgery Market is segmented as; Female, Male.
  • By Procedure: Based on the Procedure, Global Cosmetic Surgery Market is segmented as; Non-Surgical Procedure, Surgical Procedure.
  • By Age Group: Based on the Age Group, Global Cosmetic Surgery Market is segmented as; 18 Years and Younger, 19 to 34 Years, 35 to 50 Years, 51 to 64 Years, 65 Years & Above.
  • By Provider: Based on the Provider, Global Cosmetic Surgery Market is segmented as; Hospitals & Speciality Clinics, Spas & Cosmetic Surgery Centres.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impacts on the Global Cosmetic Surgery Market

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTER's Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Cosmetic Surgery Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Cosmetic Surgery Market

7. Global Cosmetic Surgery Market, By Gender (USD Million)

  • 7.1. Global Cosmetic Surgery Market Value Share and Forecast, By Gender, 2023-2033
  • 7.2. Female
  • 7.3. Male

8. Global Cosmetic Surgery Market, By Procedure (USD Million)

  • 8.1. Global Cosmetic Surgery Market Value Share and Forecast, By Procedure, 2023-2033
  • 8.2. Non-Surgical Procedure
  • 8.3. Surgical Procedure

9. Global Cosmetic Surgery Market, By Age Group (USD Million)

  • 9.1. Global Cosmetic Surgery Market Value Share and Forecast, By Age Group, 2023-2033
  • 9.2. 18 Years and Younger
  • 9.3. 19 to 34 Years
  • 9.4. 35 to 50 Years
  • 9.5. 51 to 64 Years
  • 9.6. 65 Years & Above

10. Global Cosmetic Surgery Market, By Provider (USD Million)

  • 10.1. Global Cosmetic Surgery Market Value Share and Forecast, By Provider, 2023-2033
  • 10.2. Hospitals & Speciality Clinics
  • 10.3. Spas & Cosmetic Surgery Centres

11. Global Cosmetic Surgery Market Forecast, 2019-2033 (USD Million)

  • 11.1. Global Cosmetic Surgery Market Size and Market Share

12. Global Cosmetic Surgery Market, By Gender 2019-2033 (USD Million)

  • 12.1. Global Cosmetic Surgery Market Size and Market Share by Gender (2019-2026)
  • 12.2. Global Cosmetic Surgery Market Size and Market Share by Gender (2027-2033)

13. Global Cosmetic Surgery Market, By Procedure, 2019-2033 (USD Million)

  • 13.1. Global Cosmetic Surgery Market Size and Market Share by Procedure (2019-2026)
  • 13.2. Global Cosmetic Surgery Market Size and Market Share by Procedure (2027-2033)

14. Global Cosmetic Surgery Market, By Age Group, 2019-2033 (USD Million)

  • 14.1. Global Cosmetic Surgery Market Size and Market Share by Age Group (2019-2026)
  • 14.2. Global Cosmetic Surgery Market Size and Market Share by Age Group (2027-2033)

15. Global Cosmetic Surgery Market, By Provider, 2019-2033 (USD Million)

  • 15.1. Global Cosmetic Surgery Market Size and Market Share by Provider (2019-2026)
  • 15.2. Global Cosmetic Surgery Market Size and Market Share by Provider (2027-2033)

16. Global Cosmetic Surgery Market, By Region, 2019-2033 (USD Million)

  • 16.1. Global Cosmetic Surgery Market Size and Market Share by Region (2019-2026)
  • 16.2. Global Cosmetic Surgery Market Size and Market Share by Region (2027-2033)
  • 16.3. Asia-Pacific
    • 16.3.1. Australia
    • 16.3.2. China
    • 16.3.3. India
    • 16.3.4. Japan
    • 16.3.5. South Korea
    • 16.3.6. Rest of Asia-Pacific
  • 16.4. Europe
    • 16.4.1. France
    • 16.4.2. Germany
    • 16.4.3. Italy
    • 16.4.4. Spain
    • 16.4.5. United Kingdom
    • 16.4.6. Rest of Europe
  • 16.5. Middle East and Africa
    • 16.5.1. Kingdom of Saudi Arabia
    • 16.5.2. United Arab Emirates
    • 16.5.3. Rest of Middle East & Africa
  • 16.6. North America
    • 16.6.1. Canada
    • 16.6.2. Mexico
    • 16.6.3. United States
  • 16.7. Latin America
    • 16.7.1. Argentina
    • 16.7.2. Brazil
    • 16.7.3. Rest of Latin America

17. Company Profile

  • 17.1. AbbVie Inc.
    • 17.1.1. Company details
    • 17.1.2. Financial outlook
    • 17.1.3. Product summary
    • 17.1.4. Recent developments
  • 17.2. Apyx Medical
    • 17.2.1. Company details
    • 17.2.2. Financial outlook
    • 17.2.3. Product summary
    • 17.2.4. Recent developments
  • 17.3. Bausch Health Companies Inc.
    • 17.3.1. Company details
    • 17.3.2. Financial outlook
    • 17.3.3. Product summary
    • 17.3.4. Recent developments
  • 17.4. Cutera
    • 17.4.1. Company details
    • 17.4.2. Financial outlook
    • 17.4.3. Product summary
    • 17.4.4. Recent developments
  • 17.5. Cynosure
    • 17.5.1. Company details
    • 17.5.2. Financial outlook
    • 17.5.3. Product summary
    • 17.5.4. Recent developments
  • 17.6. GALDERMA
    • 17.6.1. Company details
    • 17.6.2. Financial outlook
    • 17.6.3. Product summary
    • 17.6.4. Recent developments
  • 17.7. Johnson & Johnson Services, Inc.
    • 17.7.1. Company details
    • 17.7.2. Financial outlook
    • 17.7.3. Product summary
    • 17.7.4. Recent developments
  • 17.8. Long Island Plastic Surgical Group, PC
    • 17.8.1. Company details
    • 17.8.2. Financial outlook
    • 17.8.3. Product summary
    • 17.8.4. Recent developments
  • 17.9. Merz Pharma
    • 17.9.1. Company details
    • 17.9.2. Financial outlook
    • 17.9.3. Product summary
    • 17.9.4. Recent developments
  • 17.10. Sientra Inc.
    • 17.10.1. Company details
    • 17.10.2. Financial outlook
    • 17.10.3. Product summary
    • 17.10.4. Recent developments
  • 17.11. Others

18. List of Abbreviations

19. Reference Links

20. Conclusion

21. Research Scope